NSE BSE
alpa laboratories ltd stock

ALPA LABORATORIES LTD Share Price

- - (%)
Sector: -

14848

532878

ALPA

img img img img
No Data Available

ALPA LABORATORIES LTD Share Price Update


As of the latest trading session, ALPA LABORATORIES LTD share price is currently at 90, which is up by 0.75 from its previous closing. Today, the stock has fluctuated between 86.85 and 91.30. Over the past year, ALPA LABORATORIES LTD has achieved a return of 48.13 %. In the last month alone, the return has been -0.50 %.

ALPA LABORATORIES LTD Performance

Day Range

Low86.85 High91.30
89.75

52 Week Range

Low 55.00 High 115.00
89.75

Open Price

91.30

Prev. Close

89.25

Volume (Shares)

17308.00

Total traded value

15.53

Upper Circuit

93.70

Lower Circuit

84.80

Note: The current prices & values are delayed, Login to your account for live updates.

ALPA LABORATORIES LTD Fundamentals


(Standalone)

Market Cap (Cr) 189.36
PE Ratio (TTM) 10.58
Book Value / Share 72.86
Beta 0.76
ROE 7.26%
EPS (TTM) 8.50
Dividend Yield 0.00%
Net Profit Qtr (Cr) 4.53

ALPA LABORATORIES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 27.31
Operating Expense 25.54
Net Profit 4.53
Net Profit Margin (%) 16.58
Earnings Per Share (EPS) 2.15
EBITDA 6.01
Effective Tax Rate (%) 14.84
Particulars SEP 2023 (Values in Cr)
Revenue 32.39
Operating Expense 29.61
Net Profit 5.74
Net Profit Margin (%) 17.72
Earnings Per Share (EPS) 2.75
EBITDA 6.27
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 25.43
Operating Expense 26.87
Net Profit 3.03
Net Profit Margin (%) 11.91
Earnings Per Share (EPS) 1.44
EBITDA 3.33
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 29.16
Operating Expense 20.48
Net Profit 4.62
Net Profit Margin (%) 15.84
Earnings Per Share (EPS) 2.09
EBITDA 8.50
Effective Tax Rate (%) 41.74
Particulars DEC 2022 (Values in Cr)
Revenue 27.31
Operating Expense 24.86
Net Profit 5.14
Net Profit Margin (%) 18.82
Earnings Per Share (EPS) 2.45
EBITDA 5.31
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 92.44
Operating Expense 86.42
Net Profit 12.63
Net Profit Margin (%) 13.66
Earnings Per Share (EPS) 5.90
EBITDA 17.47
Effective Tax Rate (%) 20.77
Particulars MAR 2022 (Values in Cr)
Revenue 112.27
Operating Expense 103.47
Net Profit 14.13
Net Profit Margin (%) 12.58
Earnings Per Share (EPS) 6.71
EBITDA 21.47
Effective Tax Rate (%) 27.83
Particulars MAR 2021 (Values in Cr)
Revenue 97.55
Operating Expense 91.16
Net Profit 7.26
Net Profit Margin (%) 7.44
Earnings Per Share (EPS) 3.46
EBITDA 12.12
Effective Tax Rate (%) 32.71
Particulars MAR 2020 (Values in Cr)
Revenue 85.97
Operating Expense 83.86
Net Profit 4.08
Net Profit Margin (%) 4.74
Earnings Per Share (EPS) 1.95
EBITDA 6.42
Effective Tax Rate (%) 19.68
Particulars MAR 2019 (Values in Cr)
Revenue 77.99
Operating Expense 78.42
Net Profit 2.95
Net Profit Margin (%) 3.78
Earnings Per Share (EPS) 1.37
EBITDA 6.29
Effective Tax Rate (%) 36.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 63.96
ROE % 7.76
ROCE % 9.69
Total Debt to Total Equity 0.03
EBITDA Margin 15.21
Particulars MAR 2022 (Values in Cr)
Book Value / Share 57.86
ROE % 6.73
ROCE % 9.30
Total Debt to Total Equity 0.03
EBITDA Margin 11.23
Particulars MAR 2021 (Values in Cr)
Book Value / Share 51.16
ROE % 4.99
ROCE % 7.44
Total Debt to Total Equity 0.00
EBITDA Margin 9.22
Particulars MAR 2020 (Values in Cr)
Book Value / Share 47.70
ROE % 2.66
ROCE % 5.35
Total Debt to Total Equity 0.01
EBITDA Margin 9.94
Particulars MAR 2019 (Values in Cr)
Book Value / Share 46.81
ROE % 0.89
ROCE % 2.86
Total Debt to Total Equity 0.04
EBITDA Margin 7.73
Particulars MAR 2023 (Values in Cr)
Book Value / Share 68.69
ROE % 7.26
ROCE % 8.99
Total Debt to Total Equity 0.03
EBITDA Margin 15.20
Particulars MAR 2022 (Values in Cr)
Book Value / Share 62.56
ROE % 6.22
ROCE % 8.60
Total Debt to Total Equity 0.02
EBITDA Margin 11.25
Particulars MAR 2021 (Values in Cr)
Book Value / Share 55.85
ROE % 4.53
ROCE % 6.77
Total Debt to Total Equity 0.00
EBITDA Margin 9.19
Particulars MAR 2020 (Values in Cr)
Book Value / Share 52.39
ROE % 4.98
ROCE % 6.75
Total Debt to Total Equity 0.01
EBITDA Margin 9.90
Particulars MAR 2019 (Values in Cr)
Book Value / Share 50.44
ROE % 2.82
ROCE % 4.78
Total Debt to Total Equity 0.04
EBITDA Margin 8.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.81
Total Assets 167.26
Total Liabilities 167.26
Total Equity 134.57
Share Outstanding 21040600
Price to Book Ratio 0.78
Return on Assets (%) 7.52
Return on Capital (%) 9.19
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.57
Total Assets 155.23
Total Liabilities 155.23
Total Equity 121.73
Share Outstanding 21040600
Price to Book Ratio 1.11
Return on Assets (%) 9.07
Return on Capital (%) 11.05
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 10.51
Total Assets 140.36
Total Liabilities 140.36
Total Equity 107.64
Share Outstanding 21040600
Price to Book Ratio 0.65
Return on Assets (%) 5.16
Return on Capital (%) 6.72
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.16
Total Assets 121.35
Total Liabilities 121.35
Total Equity 100.37
Share Outstanding 21040600
Price to Book Ratio 0.27
Return on Assets (%) 1.52
Return on Capital (%) 1.84
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.89
Total Assets 121.21
Total Liabilities 121.21
Total Equity 98.49
Share Outstanding 21040600
Price to Book Ratio 0.53
Return on Assets (%) 0.83
Return on Capital (%) 1.01
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.79
Total Assets 177.50
Total Liabilities 177.50
Total Equity 144.52
Share Outstanding 21040600
Price to Book Ratio 0.78
Return on Assets (%) 7.11
Return on Capital (%) 8.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.31
Total Assets 165.13
Total Liabilities 165.13
Total Equity 131.63
Share Outstanding 21040600
Price to Book Ratio 1.11
Return on Assets (%) 8.55
Return on Capital (%) 10.27
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 10.23
Total Assets 150.23
Total Liabilities 150.23
Total Equity 117.52
Share Outstanding 21040600
Price to Book Ratio 0.65
Return on Assets (%) 4.83
Return on Capital (%) 6.17
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 5.91
Total Assets 131.20
Total Liabilities 131.20
Total Equity 110.23
Share Outstanding 21040600
Price to Book Ratio 0.27
Return on Assets (%) 3.10
Return on Capital (%) 3.69
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.88
Total Assets 128.82
Total Liabilities 128.82
Total Equity 106.12
Share Outstanding 21040600
Price to Book Ratio 0.53
Return on Assets (%) 2.28
Return on Capital (%) 2.74
Particulars MAR 2023 (Values in Cr)
Net Income 15.68
Cash from Operations 12.49
Cash from Investing 2.12
Cash from Financing -3.79
Net change in Cash 7.23
Free Cash Flow 13.62
Particulars MAR 2022 (Values in Cr)
Net Income 19.56
Cash from Operations 13.05
Cash from Investing -15.60
Cash from Financing 5.44
Net change in Cash -0.22
Free Cash Flow 15.24
Particulars MAR 2021 (Values in Cr)
Net Income 10.79
Cash from Operations 1.15
Cash from Investing 5.86
Cash from Financing 0.19
Net change in Cash 4.34
Free Cash Flow 4.37
Particulars MAR 2020 (Values in Cr)
Net Income 2.90
Cash from Operations 18.94
Cash from Investing -11.16
Cash from Financing -1.34
Net change in Cash 5.27
Free Cash Flow 21.48
Particulars MAR 2019 (Values in Cr)
Net Income 2.75
Cash from Operations 1.16
Cash from Investing -14.66
Cash from Financing -4.77
Net change in Cash -20.44
Free Cash Flow 2.01
Particulars MAR 2023 (Values in Cr)
Net Income 15.72
Cash from Operations 12.22
Cash from Investing 2.13
Cash from Financing -3.47
Net change in Cash 7.47
Free Cash Flow 13.35
Particulars MAR 2022 (Values in Cr)
Net Income 19.57
Cash from Operations 5.77
Cash from Investing -15.60
Cash from Financing 5.41
Net change in Cash -7.99
Free Cash Flow 7.96
Particulars MAR 2021 (Values in Cr)
Net Income 10.79
Cash from Operations 1.39
Cash from Investing 5.81
Cash from Financing -0.02
Net change in Cash 4.32
Free Cash Flow 4.61
Particulars MAR 2020 (Values in Cr)
Net Income 5.07
Cash from Operations 18.76
Cash from Investing -11.27
Cash from Financing -1.35
Net change in Cash 5.03
Free Cash Flow 21.30
Particulars MAR 2019 (Values in Cr)
Net Income 4.62
Cash from Operations 1.41
Cash from Investing -14.94
Cash from Financing -4.77
Net change in Cash -20.40
Free Cash Flow 2.26
Company Name Price P/E P/B Market Cap 52 Week Low/High
ALPA LABORATORIES LTD 90.15 10.57 1.32 189.68 55.10 / 115.00
BLISS GVS PHARMA LTD 110.40 12.07 1.19 1155.79 71.00 / 148.95
CIPLA LTD 1403.90 26.62 4.24 113350.18 913.20 / 1519.00
FERMENTA BIOTECH LIMITED 162.85 0.00 1.67 479.28 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2355.75 57.70 22.44 39907.83 1275.05 / 2649.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
ALPA LABORATORIES LTD 90.15 10.61 1.23 189.68 55.10 / 115.00
AMRUTAJAN HEALTH LTD 743.15 48.83 8.20 2148.49 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.35 90.24 21.97 14393.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 110.40 15.25 1.16 1155.79 71.00 / 148.95
ABBOTT INDIA LIMITED 26643.70 47.13 15.30 56617.86 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 89.80
  • 26 Days 92.10
  • 10 Days 90.70
  • 50 Days 93.10
  • 12 Days 91.10
  • 100 Days 95.20
  • 20 Days 91.40
  • 200 Days 73.10
89.40
PIVOT
First Resistance 91.70
Second Resistance 94.15
Third Resistance 96.45
First Support 86.95
Second Support 84.65
Third Support 82.20
RSI 29.11
MACD -0.96
Commodity Channel Index (CCI) -98.26
ADX 28.45
Williams % R -81.93

Over 1 Month

down

-0.50

Over 3 Months

down

-13.34

Over 6 Months

down

-5.90

Over 1 Year

down

48.13

Over 3 Years

down

18.15

Over 5 Years

down

31.03

ALPA LABORATORIES LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ALPA LABORATORIES LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
42.2
Promoter Holdings
57.29
FII
0.5
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Paresh Chawla Shareholding of Promoter and Promoter Group 3686450.0 17.52
Mahendra Singh Chawla Shareholding of Promoter and Promoter Group 2906760.0 13.82
Pravin Shah Shareholding of Promoter and Promoter Group 1210580.0 5.75
Bakulesh Shah Shareholding of Promoter and Promoter Group 1026600.0 4.88
Shitul Shah Shareholding of Promoter and Promoter Group 925200.0 4.4
Rima Shah Shareholding of Promoter and Promoter Group 775200.0 3.68
Asha Chawla Shareholding of Promoter and Promoter Group 616700.0 2.93
Rupal Shah Shareholding of Promoter and Promoter Group 558780.0 2.66
Soni Chawla Shareholding of Promoter and Promoter Group 326800.0 1.55
Bakulesh Chandulal Shah Huf Shareholding of Promoter and Promoter Group 21940.0 0.1
Saraswati Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Pooja Chawla Shareholding of Promoter and Promoter Group 0.0 0.0
Mitin Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Meeta Sethi Shareholding of Promoter and Promoter Group 0.0 0.0

ALPA LABORATORIES LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ALPA LABORATORIES LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ALPA LABORATORIES LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Alpa Laboratories Ltd?

Answer Field

The share price of Alpa Laboratories Ltd for NSE is ₹ 90 and for BSE is ₹ 89.6.

What is the Market Cap of Alpa Laboratories Ltd?

Answer Field

The market cap of Alpa Laboratories Ltd for NSE is ₹ 189.36 Cr. and for BSE is ₹ 188.52 Cr. as of now.

What is the 52 Week High and Low of Alpa Laboratories Ltd?

Answer Field

The 52 Week High and Low of Alpa Laboratories Ltd for NSE is ₹ 115.00 and ₹ 55.00 and for BSE is ₹ 115.00 and ₹ 55.10.

How to Buy Alpa Laboratories Ltd share?

Answer Field

You can trade in Alpa Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Alpa Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 48.13%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader